Skip to main content

Management of Medical Emergency-Anaphylaxis!

 MEDICAL EMERGENCY- ANAPHYLAXIS

Definition:

"Anaphylaxis is a systemic response to exposure to an allergen caused by rapid, IgE-mediatd release of histamine and other mediators from tissue mast cells and circulating basophils".

Symptoms:

  • Symptoms usually occur within a few seconds or minutes of exposure but can be delayed or recur many hours after apparent resolution (exposure).

Causes:

  1. Upper airway obstruction
  2. Cardiovascular collapse

are the most common causes of death in anaphylaxis.

Treatment:

The treatment of anaphylaxis is directed towards its three Major Presentations:

  1. Skin Manifestations: Angioedema, Urticaria
  2. Respiratory distress: Wheezing, Stridor, Dyspnea from laryngeal edema, laryngospasm and bronchospasm
  3. Hypotension

All specific treatment measures should be accompanied by basic resuscitative measures including clear airway, supplemented oxygen and IV access.

General Therapy and Skin Manifestations:

1. Epinephrine HCl, IM or SC, 0.3-0.5mg; may repeat q(every) 10-15 minutes. In children, 10microgram/kg up to 500 microgram/dose.

2. Diphenhydramine, IV or IM, 1-2mg/kg (up to 50mg) over 5-10 minutes.

3. Cimetidine, IV, 300mg over 5 minutes for urticaria or if hypotension does not respond to fluid replacement and pressors. In children, 3-5mg/kg IV.

4. Although controversial, corticosteroids such as Hydrocortisone phosphate or Succinate, IV, 200mg or Methylprednisolone, IV, 1-2mg/kg might reduce the risk of recurrent or prolonged anaphylaxis.

Respiratory Distress:

1. Assure adequate oxygenation with supplemented oxygen by mask titrated to an oxygen saturation above 90%.

2. In addition to the general therapy described above, add Albuterol, by nebulization, 2.5-5mg q 20 minutes. In children, 0.15mg/kg by nebulization q 20 minutes.

3. If response is inadequate after 3-4 doses of intermittent Albuterol, consider Albuterol, by continuous nebulization, 10-15mg/hr. In children, 0.5mg/kg/hr. by continuous nebulization.

Hypotension:

1. If response to the general therapy described above is inadequate, give NS or Lactated Ringers Injection, IV, 500-1000mL initially and continue at high flow rate. In children, 10-20mL/kg IV initially.

2. Epinephrine HCl, IV continuous infusion, 1 microgram/min, up to 10 microgram/min.

3. Dopamine HCl, IV, 2-5 microgram/kg/minute, titrate to desired effect.

4. Patients taking Beta-adrenergic Blockers may not respond adequately to epinephrine and Fluid replacement and can be adversely affected by unopposed Alpha-adrenergic stimulation from Epinephrine. Glucagon, IV, 5-10mg followed by 1-5mg/hr. by continuous infusion can increase myocardial contractility independent of Beta receptors.


Information notes:

*Salbutamol is also known as Albuterol (Beta2 adrenergic agonist).

Lactated Ringers solution also known as Sodium lactate solution. For replacing fluids and electrolytres.

Glucagon is a peptide hormone produced by Alpha cells of pancreas. It causes increased glucose and fatty acids in blood stream. Also considered as a Catabolic hormone



Labels:

Comments

Post a Comment

Popular posts from this blog

General Mechanism of Actions of INSULIN.

GENERAL MECHANISM OF ACTION OF INSULIN AND RELATE HORMONES The body's main fuel is Glucose. Glucose is stored in the liver and muscles as Glycogen.  Excess glucose is stored in the adipose tissues which yield fatty acids via lipolysis. In the fasting state, free fatty acids supply much of the energy needs of the body except for the CNS which requires Glucose to function normally. Proteins can also be converted to glucose via gluconeogenesis. RELEASE OF INSULIN AND GLUCAGON Insulin and Glucagon are produced in the pancreas by the Islets of Langerhans . Beta cells   make up 70%-90% of the Islets and produce Insulin and Amylin while the a-cells   produce glucagon. The main function of insulin is to decrease blood glucose levels. Glucagon, along with other counter-regulatory hormones such as growth factor, cortisol, and Epinephrine, increases Blood glucose levels.  The opposing actions of Glucagon and Insulin along with other counter-regulatory hormones maintain a norma...
Post a Comment
Read more

Diabetes Mellitus: Its Goals Of Therapy!

  GOAL OF THERPY The goals of treatment of DM includes; Reducing, controlling and managing long-term microvascular, macrovascular and neuropaathic complications. Preserving beta cell function. Preventing acute complications from increased Blood glucosel level. Minimizing hypoglycemic episodes. Maintaining patient quality of life. --Two landmark trials, THE DIABETES CONTROL AND COMPLICATION TRIAL (DCCT) and THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY(UKPDS), showed that lowering blood glucose levels decreased the risk of developing chronic complications. --A near normal blood glucose level can be achieved with appropriate patient education , lifestyle modification and medications . --Proper care of DM requires goal setting and assessment for glycemic control , self-monitoring of blood glucose (SMBG) monitoring of blood glucose pressure , and lipid levels , regular monitoring for the development of complications , dietary and exercise lifestyle modifications and proper medicatio...
Post a Comment
Read more

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more